Medicine and Dentistry
Gut Microbiome
100%
Synuclein
100%
Glucan
100%
Therapeutic Agent
50%
Gut
50%
Adjuvant Therapy
50%
Neuroblastoma Cell Line
50%
Neurodegenerative Disorder
50%
Endoplasmic Reticulum Stress
50%
Exopolysaccharide
50%
SH-SY5Y
50%
Mitochondrial Disorder
50%
Dysbiosis
50%
Protein Misfolding
50%
Alpha Synuclein
50%
Pullulan
50%
Keyphrases
Gut Microbiome
100%
Misfolding
100%
Alpha-synuclein (α-syn)
100%
Neurological Conditions
100%
Therapeutic Agents
25%
Inflammation
25%
Neurodegenerative Diseases
25%
Biological Response
25%
Adjunctive Therapy
25%
Therapeutic Strategies
25%
Protein Misfolding
25%
Modulating Activity
25%
Gut-brain Axis
25%
Endoplasmic Reticulum Stress (ER stress)
25%
Neurodegenerative Conditions
25%
Mitochondrial Dysfunction
25%
Exopolysaccharide
25%
SH-SY5Y Cells
25%
Glucan
25%
Human Neuroblastoma Cell Line
25%
Gut Dysbiosis
25%
Cellular Pathology
25%
Epigenetic Stability
25%
Neurodevelopmental Conditions
25%
Aureobasidium Pullulans
25%
6-glucan
25%
Neuroscience
Synuclein
100%
Glucan
100%
Cell Line
50%
Neurodegenerative Disorder
50%
In Vivo
50%
Neuroblastoma
50%
Protein Misfolding
50%
Adjuvant Therapy
50%
Neurodevelopmental Disorder
50%
Endoplasmic Reticulum Stress
50%
Alpha-Synuclein
50%
Pullulan
50%
Exopolysaccharide
50%
Biochemistry, Genetics and Molecular Biology
Synuclein
100%
Glucan
100%
Gut Microbiome
100%
Protein Misfolding
50%
Epigenetics
50%
Mitochondrial Disorder
50%
Endoplasmic Reticulum Stress
50%
Alpha-Synuclein
50%
Aureobasidium pullulans
50%
Grand Unified Theory
50%